Michael Lein
Offenbach, HE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Safety with the senhance™ robotic system in 3,239 patients across various surgical disciplines.
Journal: Langenbeck's archives of surgery
Published: January 18, 2025
Vitamin D Metabolites in Nonmetastatic High-Risk Prostate Cancer Patients with and without Zoledronic Acid Treatment after Prostatectomy.
Journal: Cancers
Published: February 22, 2022
Comparison of PHI and PHI Density for Prostate Cancer Detection in a Large Retrospective Caucasian Cohort.
Journal: Urologia internationalis
Published: March 23, 2021
The discriminative ability of Prostate Health Index to detect prostate cancer is enhanced in combination with miR-222-3p.
Journal: Cancer biomarkers : section A of Disease markers
Published: December 28, 2020
PHI density prospectively improves prostate cancer detection.
Journal: World journal of urology
Published: August 11, 2020
Integration of tissue metabolomics, transcriptomics and immunohistochemistry reveals ERG- and gleason score-specific metabolomic alterations in prostate cancer.
Journal: Oncotarget
Published: July 14, 2015
Synthesis, crystal structure and effect of indeno[1,2-b]indole derivatives on prostate cancer in vitro. Potential effect against MMP-9.
Journal: European journal of medicinal chemistry
Published: October 06, 2014
Urinary thiosulfate as failed prostate cancer biomarker - an exemplary multicenter re-evaluation study.
Journal: Clinical chemistry and laboratory medicine
Published: July 15, 2014
Bone turnover markers in serum and urine as diagnostic, prognostic and monitoring biomarkers of bone metastasis.
Journal: Biochimica et biophysica acta
Published: June 12, 2014
Serum testosterone improves the accuracy of Prostate Health Index for the detection of prostate cancer.
Journal: Clinical biochemistry
Published: November 24, 2013
Last Updated: 09/26/2026